Equity to Asset ratio is calculated as total stockholders equity divided by total asset. The Cooper's Total Stockholders Equity for the quarter that ended in Oct. 2024 was $8,083 Mil. The Cooper's Total Assets for the quarter that ended in Oct. 2024 was $12,315 Mil.
Therefore, The Cooper's Equity to Asset Ratio for the quarter that ended in Oct. 2024 was 0.66.
The historical rank and industry rank for The Cooper's Equity-to-Asset or its related term are showing as below:
COO'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54 Med: 0.61 Max: 0.72
Current: 0.66
During the past 13 years, the highest Equity to Asset Ratio of The Cooper was 0.72. The lowest was 0.54. And the median was 0.61.
COO's Equity-to-Asset is ranked better than 54.15% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs COO: 0.66
The Cooper Equity-to-Asset Historical Data
The historical data trend for The Cooper's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Cooper's Equity-to-Asset
For the Medical Instruments & Supplies subindustry, The Cooper's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where The Cooper's Equity-to-Asset falls into.
The Cooper Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
The Cooper's Equity to Asset Ratio for the fiscal year that ended in Oct. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (NAS:COO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
The Cooper Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of The Cooper's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 